Registered entities
Aveo Pharmaceuticals, Inc.
Reg. No. 43581650United States
Aveo Pharmaceuticals Inc
Reg. No. 1325879United States
Aveo Pharmaceuticals, Inc.
Reg. No. 731960United States
AVEO
Reg. No. 40003219745Latvia
Innovation
47 patent families (24 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 4,638 times.
| Year | Filings |
|---|---|
| 2015 | 11 |
| 2016 | 8 |
| 2017 | 9 |
| 2018 | 5 |
| 2019 | 7 |
| 2020 | 5 |
| 2021 | 9 |
| 2022 | 5 |
| 2023 | 7 |
| 2024 | 3 |
| 2025 | 7 |
| 2026 | 4 |
Social engagement
Social engagement: 25.8K social following, 10 posts in the last 12 months — around the industry typical range.
Investor mix
16 investors on record; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 9 | 56% |
| Private equity | 1 | 6% |
| Bank & private debt | 2 | 13% |
| Other / undisclosed | 4 | 25% |
Hiring activity
Hires periodically
3 roles tracked across 3 of the last 12 months
1 Mar 2026 · Oncology Account Manager · Philadelphia
8 Dec 2025 · Director, Federal Markets · Boston
4 Nov 2025 · Senior Manager, Quality Systems · Boston
27 Aug 2025 · Administrative Assistant · Boston
11 Aug 2025 · Senior Clinical Trial Assistant · Boston
Based on job postings tracked across public sources.
Recent activity
1 Jul 2026
Leadership hire
President and Chief Executive Officer
24 Jun 2026
Event
American Society of Clinical Oncology (ASCO) Annual Meeting